Onapgo Injection, Solution
Product Images NDC 27505-006

387 FDA label images from Mdd Us Operations, Llc, A Subsidiary Of Supernus Pharmaceuticals, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 387 technical images submitted to the FDA as part of the official labeling for Onapgo (NDC 27505-006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mdd Us Operations, Llc, A Subsidiary Of Supernus Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Onapgo 01)

Chemical Structure (Onapgo 01)
Chemical structure of Apomorphine hydrochloride, showing the molecular framework of the active ingredient in ONAPGO 4.9 mg/mL injection solution.*
FDA Label Image

Figure 2 (Onapgo 02)

Figure 2 (Onapgo 02)
A line chart depicting changes from baseline in hours of ON time without troublesome dyskinesia and OFF time over 12 weeks of treatment with ONAPGO or placebo. The graph shows ONAPGO and placebo groups for both ON and OFF times, with numerical sample sizes noted for each week point.*
FDA Label Image

Figure 3 (Onapgo 03)

Figure 3 (Onapgo 03)
A bar chart comparing the percentage of subjects reporting various levels of improvement or worsening between ONAPGO injection (4.9 mg/mL) and placebo groups. Categories include Very Much Improved, Much Improved, Minimally Improved, No Change, Minimally Worse, Much Worse, and Very Much Worse, with percentages displayed for each group.*
FDA Label Image

Image (Onapgo 04)

Image (Onapgo 04)
ONAPGO 4.9 mg/mL injection, solution in a subcutaneous delivery device. The label shows the proprietary name ONAPGO and the generic name Apomorphine hydrochloride, with dosage strength 4.9 mg/mL. The device includes a digital control panel with buttons for dose, back, menu, and OK. Labeler is MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*
FDA Label Image

Image (Onapgo 05)

Image (Onapgo 05)
ONAPGO 4.9 mg/mL injection, solution in a clear vial with a blue and white label. The vial is intended for subcutaneous use and is labeled with the generic name Apomorphine hydrochloride. The product is distributed by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*
FDA Label Image

Image (Onapgo 06)

FDA Label Image

Image (Onapgo 06a)

FDA Label Image

Figure A (Onapgo 07)

Figure A (Onapgo 07)
Illustration of a medical infusion pump kit showing labeled components including a pump pouch, elastic belt, infusion pump device with display, spare CR123 battery, battery door key, and a lanyard, all contained within an open carrying case.*
FDA Label Image

Figure B, C, D (Onapgo 08)

Figure B, C, D (Onapgo 08)
Illustration of a subcutaneous injection device interface for ONAPGO (apomorphine hydrochloride) 4.9 mg/mL. The device features a display screen, multiple control buttons including arrows, menu, OK, and function keys, and ports for injection components labeled with letters a through j for user guidance.*
FDA Label Image

Image (Onapgo 05a)

Image (Onapgo 05a)
ONAPGO injection, solution 4.9 mg/mL in a clear glass vial with a purple cap. The label shows the proprietary name ONAPGO and the active ingredient Apomorphine hydrochloride. The vial contains 3 mL of the solution and is manufactured by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*
FDA Label Image

Image (Onapgo 11)

Image (Onapgo 11)
ONAPGO 4.9 mg/mL Apomorphine hydrochloride subcutaneous injection solution. The image shows a vial's label featuring the product name, strength, dosage form, and administration route. The label includes a dose icon with a plus symbol and the word 'DOSE.' Labeler indicated as MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*
FDA Label Image

Image (Onapgo 12)

FDA Label Image

Image (Onapgo 13)

FDA Label Image

Image (Onapgo 14)

FDA Label Image

Image (Onapgo 15)

FDA Label Image

Image (Onapgo 16)

FDA Label Image

Image (Onapgo 17)

FDA Label Image

Image (Onapgo 18)

FDA Label Image

Image (Onapgo 19)

FDA Label Image

Image (Onapgo 20)

FDA Label Image

Image (Onapgo 21)

FDA Label Image

Image (Onapgo 22)

FDA Label Image

Image (Onapgo 23)

FDA Label Image

Image (Onapgo 11a)

Image (Onapgo 11a)
ONAPGO 4.9 mg/mL Apomorphine hydrochloride subcutaneous injection, solution label. The label includes dosage information and the product logo with a cross and the word 'DOSE'. The product is manufactured by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*
FDA Label Image

Image (Onapgo 24)

FDA Label Image

Image (Onapgo 25)

FDA Label Image

Figure E (Onapgo 26)

FDA Label Image

Image (Onapgo 06b)

FDA Label Image

Image (Onapgo 05b)

Image (Onapgo 05b)
ONAPGO 4.9 mg/mL injection, solution in a subcutaneous injectable format. The packaging shows a single-dose vial with a purple cap and labeling that includes the proprietary name, concentration, and manufacturer MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*
FDA Label Image

Figure F (Onapgo 29)

FDA Label Image

Figure G (Onapgo 28)

FDA Label Image

Image (Onapgo 29a)

FDA Label Image

Figure H (Onapgo 30)

FDA Label Image

Image (Onapgo 31)

FDA Label Image

Figure I (Onapgo 33)

FDA Label Image

Image (Onapgo 32)

FDA Label Image

Figure J (Onapgo 34)

FDA Label Image

Figure K (Onapgo 35)

FDA Label Image

Image (Onapgo 32a)

FDA Label Image

Figure M (Onapgo 36)

FDA Label Image

Image (Onapgo 32b)

FDA Label Image

Figure O (Onapgo 37)

FDA Label Image

Image (Onapgo 32c)

FDA Label Image

Figure Q (Onapgo 38)

FDA Label Image

Image (Onapgo 32d)

FDA Label Image

Figure S (Onapgo 39)

FDA Label Image

Image (Onapgo 32e)

FDA Label Image

Figure U (Onapgo 40)

FDA Label Image

Image (Onapgo 32f)

FDA Label Image

Figure W (Onapgo 41)

FDA Label Image

Image (Onapgo 32g)

FDA Label Image

Figure Y (Onapgo 42)

FDA Label Image

Figure Z (Onapgo 43)

FDA Label Image

Figure Aa (Onapgo 44)

FDA Label Image

Image (Onapgo 06c)

FDA Label Image

Image (Onapgo 06d)

FDA Label Image

Figure Ab (Onapgo 44a)

FDA Label Image

Figure Ac (Onapgo 44b)

FDA Label Image

Figure Ad (Onapgo 45)

FDA Label Image

Figure Ae (Onapgo 46)

FDA Label Image

Figure Af (Onapgo 47)

FDA Label Image

Figure Ag (Onapgo 48)

FDA Label Image

Figure Ah (Onapgo 49)

FDA Label Image

Figure Ai (Onapgo 50)

FDA Label Image

Figure Aj (Onapgo 51)

FDA Label Image

Figure Ak (Onapgo 52)

FDA Label Image

Figure Al (Onapgo 53)

FDA Label Image

Figure Am (Onapgo 54)

FDA Label Image

Figure An (Onapgo 55)

FDA Label Image

Image (Onapgo 06e)

FDA Label Image

Figure Ao (Onapgo 56)

FDA Label Image

Figure Ap (Onapgo 57)

FDA Label Image

Figure Aq (Onapgo 58)

FDA Label Image

Figure Ar (Onapgo 59)

FDA Label Image

Figure As (Onapgo 60)

FDA Label Image

Figure At (Onapgo 61)

FDA Label Image

Figure Au (Onapgo 62)

FDA Label Image

Figure Av (Onapgo 63)

FDA Label Image

Figure Aw (Onapgo 64)

FDA Label Image

Figure Ax (Onapgo 65)

FDA Label Image

Figure Ay (Onapgo 66)

FDA Label Image

Figure Az (Onapgo 67)

FDA Label Image

Figure Ba (Onapgo 68)

FDA Label Image

Image (Onapgo 06f)

FDA Label Image

Image (Onapgo 06g)

FDA Label Image

Figure Bb (Onapgo 69)

FDA Label Image

Image (Onapgo 05c)

Image (Onapgo 05c)
ONAPGO 4.9 mg/mL injection, solution for subcutaneous use in a 2 mL vial. The label shows the product name, active ingredient Apomorphine hydrochloride, concentration, and manufacturer: MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*
FDA Label Image

Figure Bc (Onapgo 70)

FDA Label Image

Figure Bd (Onapgo 103)

FDA Label Image

Image (Onapgo 29ab)

FDA Label Image

Figure Be (Onapgo 71)

FDA Label Image

Figure Bf (Onapgo 72)

FDA Label Image

Image (Onapgo 32h)

FDA Label Image

Figure Bh (Onapgo 73)

FDA Label Image

Image (Onapgo 32i)

FDA Label Image

Figure Bj (Onapgo 74)

FDA Label Image

Figure Bk (Onapgo 75)

FDA Label Image

Image (Onapgo 06h)

FDA Label Image

Figure Bl (Onapgo 76)

FDA Label Image

Figure Bm (Onapgo 77)

FDA Label Image

Image (Onapgo 32j)

FDA Label Image

Image (Onapgo 32k)

FDA Label Image

Image (Onapgo 31a)

FDA Label Image

Image (Onapgo 32l)

FDA Label Image

Figure Bo (Onapgo 78)

FDA Label Image

Figure Bq (Onapgo 79)

FDA Label Image

Figure Br (Onapgo 80)

FDA Label Image

Figure Bs (Onapgo 81)

FDA Label Image

Image (Onapgo 06i)

FDA Label Image

Image (Onapgo 06j)

FDA Label Image

Image (Onapgo 06k)

FDA Label Image

Figure Bt (Onapgo 82)

FDA Label Image

Figure Bu (Onapgo 83)

FDA Label Image

Image (Onapgo 06l)

FDA Label Image

Image (Onapgo 06m)

FDA Label Image

Image (Onapgo 06n)

FDA Label Image

Figure Bv (Onapgo 84)

FDA Label Image

Figure Bw (Onapgo 85)

FDA Label Image

Figure Bx (Onapgo 86)

FDA Label Image

Image (Onapgo 05d)

Image (Onapgo 05d)
ONAPGO 4.9 mg/mL Apomorphine hydrochloride injection solution in a single-dose vial. The label displays dosage concentration, product name, and manufacturer details, MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*
FDA Label Image

Figure By (Onapgo 87)

FDA Label Image

Figure Bz (Onapgo 88)

FDA Label Image

Image (Onapgo 32m)

FDA Label Image

Figure Cb (Onapgo 89)

FDA Label Image

Image (Onapgo 32n)

FDA Label Image

Figure Cd (Onapgo 90)

FDA Label Image

Image (Onapgo 32o)

FDA Label Image

Figure Cf (Onapgo 91)

FDA Label Image

Figure Cg (Onapgo 92)

FDA Label Image

Figure Ch (Onapgo 93)

FDA Label Image

Figure Ci (Onapgo 94)

FDA Label Image

Figure Cj (Onapgo 95)

FDA Label Image

Image (Onapgo 06o)

FDA Label Image

Figure Ck (Onapgo 96)

FDA Label Image

Figure Cl (Onapgo 97)

FDA Label Image

Figure Cm (Onapgo 98)

FDA Label Image

Image (Onapgo 06p)

FDA Label Image

Figure Cn (Onapgo 99)

FDA Label Image

Figure Co (Onapgo 100)

Figure Co (Onapgo 100)
An instructional display panel showing a locked dose option symbolized by a lock icon next to a plus sign. Below, it indicates time remaining with placeholders for hours (XX hr) and minutes (XX min) followed by the word 'Remaining.' The design is monochromatic with white symbols and text on a black background.*
FDA Label Image

Figure Cp (Onapgo 101)

FDA Label Image

Figure Cq (Onapgo 102)

FDA Label Image

Image (Onapgo 05e)

Image (Onapgo 05e)
ONAPGO 4.9 mg/mL injection, solution for subcutaneous use in a 3 mL glass vial with a purple cap and purple label text. The label includes the drug name, strength, route, and manufacturer: MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*
FDA Label Image

Figure Cs (Onapgo 104)

Figure Cs (Onapgo 104)
An instructional illustration showing a hand holding a digital device with a small screen and five buttons below it labeled with icons and text: a blue cross, a yellow warning triangle, MENU, and OK, suggesting user interaction with the device controls.*
FDA Label Image

Image (Onapgo 105)

Image (Onapgo 105)
ONAPGO 4.9 mg/mL injection, solution for subcutaneous use in a vial. The label shows the product name, strength, and dosage form. It includes usage and manufacturing details by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*
FDA Label Image

Figure Ct (Onapgo 106)

Figure Ct (Onapgo 106)
An illustration of a handheld medical device with a digital screen and control buttons, used for administering subcutaneous injections. The device features two arrow buttons, a MENU button, a back/cancel button, and an OK button, with a finger pressing the back/cancel button. It has a clear cartridge on the left side for holding the injection solution.*
FDA Label Image

Image (Onapgo 31b)

FDA Label Image

Figure Cu (Onapgo 107)

Figure Cu (Onapgo 107)
A digital display screen showing a dosing prompt with the question 'Dose?' and options 'No' and 'Yes,' where 'Yes' is highlighted in yellow. An 'EXIT' option is also displayed below.*
FDA Label Image

Image (Onapgo 32p)

FDA Label Image

Figure Cw (Onapgo 108)

Figure Cw (Onapgo 108)
A black and white text panel showing a section titled 'Dose' with the phrase 'Delivering X.X mg' below it, indicating a dosage display or dosing information for a medication.*
FDA Label Image

Figure Cx (Onapgo 109)

Figure Cx (Onapgo 109)
An illustration showing the phrase 'Dose Delivered' along with a white medical cross symbol above the text and a green check mark below it, indicating successful dose delivery.*
FDA Label Image

Figure Cy (Onapgo 110)

Figure Cy (Onapgo 110)
A black and white digital display panel indicating time remaining. It features symbols and placeholders for hours and minutes with the words 'Remaining' below, likely part of a device interface showing time left for a medication or infusion.*
FDA Label Image

Image (Onapgo 06q)

FDA Label Image

Image (Onapgo 105a)

Image (Onapgo 105a)
ONAPGO 4.9 mg/mL injection, solution in a prefilled syringe for subcutaneous use. The vial label indicates apomorphine hydrochloride as the active ingredient. The label shows a clear syringe with measurement markings and includes manufacturer information: MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*
FDA Label Image

Image (Onapgo 29ac)

FDA Label Image

Figure Cz (Onapgo 111)

Figure Cz (Onapgo 111)
An illustration showing a hand pressing the green 'OK' button on the control panel of a medical device. The device features a small screen and several buttons, including an up arrow, a down arrow, and two additional buttons labeled with icons. The design suggests a user interface for programming or operating an injection or delivery device.*
FDA Label Image

Image (Onapgo 31c)

FDA Label Image

Figure Da (Onapgo 112)

Figure Da (Onapgo 112)
A digital device screen displaying a simple menu interface with options: Pause, End, and Give + Dose. The Give + Dose option is highlighted in yellow, indicating selection. The display likely relates to administration or dosage control for a medication device.*
FDA Label Image

Image (Onapgo 32q)

FDA Label Image

Image (Onapgo 31d)

FDA Label Image

Figure Dc (Onapgo 113)

Figure Dc (Onapgo 113)
An electronic device display screen showing a prompt with the text 'Dose?' at the top, followed by options 'No' and 'Yes' with 'Yes' highlighted in yellow, and an 'EXIT' option on the bottom right. The interface suggests user input selection, possibly related to dosing decisions.*
FDA Label Image

Image (Onapgo 32r)

FDA Label Image

Figure De (Onapgo 114)

Figure De (Onapgo 114)
A text panel showing dosing or timing instructions with symbols and placeholders: a plus sign next to 'X/X', followed by 'XXhr', a droplet symbol with 'XXmin', and the word 'Remaining' at the bottom. The exact numeric values are not specified.*
FDA Label Image

Image (Onapgo 105b)

Image (Onapgo 105b)
ONAPGO 4.9 mg/mL injection, solution, is a subcutaneous prescription drug in a glass vial with a gray rubber stopper and black flip-off cap. The vial label includes the drug name, strength, and manufacturer MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*
FDA Label Image

Figure Df (Onapgo 115)

Figure Df (Onapgo 115)
This image shows a digital display screen with the text "+ Dose" at the top, and below it the status message "Locked" in red with a lock icon. Further text indicates the lock duration as "For Xhr XXmin," suggesting a timed lock or dose delay feature on a device.*
FDA Label Image

Figure Dg (Onapgo 116)

FDA Label Image

Image (Onapgo 05f)

Image (Onapgo 05f)
ONAPGO 4.9 mg/mL injection, solution in a subcutaneous vial. The packaging displays the brand name ONAPGO prominently along with the active ingredient apomorphine hydrochloride. The label includes strength information and manufacturer details for MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*
FDA Label Image

Figure Dh (Onapgo 116a)

Figure Dh (Onapgo 116a)
Illustration of a handheld electronic device with a small screen and multiple buttons, including 'DOSE', 'MENU', and 'OK'. A hand is shown pressing the 'OK' button. The device appears to be used for dosage or medication management, likely related to the injection solution ONAPGO.*
FDA Label Image

Image (Onapgo 29ad)

FDA Label Image

Figure Dj (Onapgo 117)

Figure Dj (Onapgo 117)
An electronic device screen displaying a menu with four options: Pause (highlighted), End, Give + Dose, and a droplet icon at the top right corner. The screen is monochrome with white text on a black background and the Pause option is highlighted in yellow.*
FDA Label Image

Image (Onapgo 32s)

FDA Label Image

Figure Dm (Onapgo 118)

Figure Dm (Onapgo 118)
An instructional illustration depicting how to open a container or vial. It shows a hand pinching and pulling to open a device, followed by lifting off the top part. It appears to guide users through a two-step opening process for a medical or pharmaceutical product.*
FDA Label Image

Image (Onapgo 05g)

Image (Onapgo 05g)
ONAPGO 4.9 mg/mL injection, solution in a 2 mL vial for subcutaneous use. The label includes the proprietary name ONAPGO and the active ingredient apomorphine hydrochloride. It is labeled by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc. The vial displays the product NDC 27505-006.*
FDA Label Image

Figure Do (Onapgo 118b)

Figure Do (Onapgo 118b)
An illustration of a handheld medical device with a screen and buttons, including labeled buttons such as ON/OFF, MENU, and directional arrows. A hand is shown pressing the MENU button. The device appears designed for user interaction, potentially for administering or controlling medication delivery.*
FDA Label Image

Image (Onapgo 29ae)

FDA Label Image

Figure Dq (Onapgo 119)

FDA Label Image

Image (Onapgo 32t)

FDA Label Image

Figure Ds (Onapgo 120)

Figure Ds (Onapgo 120)
An illustration displaying the message 'Infusion Resumed' along with a green checkmark symbol, indicating the continuation of infusion.*
FDA Label Image

Image (Onapgo 05h)

Image (Onapgo 05h)
ONAPGO 4.9 mg/mL injection, solution for subcutaneous use in a 3 mL vial. The packaging is a rectangular box with blue and white colors. The labeler is MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*
FDA Label Image

Figure Du (Onapgo 120b)

Figure Du (Onapgo 120b)
An illustration showing a person holding a small electronic device with a display screen and four buttons labeled with icons for dose, inhale, menu, and OK. The device appears to be a dose delivery or monitoring device, related to subcutaneous injection treatment.*
FDA Label Image

Image (Onapgo 29af)

FDA Label Image

Image (Onapgo 31e)

FDA Label Image

Figure Dw (Onapgo 121)

FDA Label Image

Image (Onapgo 32u)

FDA Label Image

Image (Onapgo 31f)

FDA Label Image

Figure Dy (Onapgo 122)

Figure Dy (Onapgo 122)
A digital display screen showing a simple menu with options 'No' and 'Yes', where the 'Yes' option is highlighted in yellow. The words 'End' and 'EXIT' appear at the top and bottom corners respectively, suggesting a user interface for making a selection.*
FDA Label Image

Image (Onapgo 32v)

FDA Label Image

Figure Ea (Onapgo 123)

Figure Ea (Onapgo 123)
An instructional image with text reading, 'STOP! Remove Line From Body Press OK,' with the last line highlighted in yellow. It appears to be a prompt or instruction related to product use.*
FDA Label Image

Image (Onapgo 32w)

FDA Label Image

Figure Ed (Onapgo 124)

Figure Ed (Onapgo 124)
A digital display panel showing the message 'Please Wait Ending Infusion' in white text on a black background, indicating a pause or completion phase in an infusion process.*
FDA Label Image

Image (Onapgo 125)

Image (Onapgo 125)
ONAPGO 4.9 mg/mL injection solution in a vial for subcutaneous use. The label shows product and generic names (Apomorphine hydrochloride), strength, and vial quantity. Manufactured by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*
FDA Label Image

Image (Onapgo 32x)

FDA Label Image

Figure Ef (Onapgo 126)

FDA Label Image

Figure Eg (Onapgo 127)

FDA Label Image

Figure Eh (Onapgo 128)

FDA Label Image

Figure Ei (Onapgo 129)

FDA Label Image

Image (Onapgo 06r)

FDA Label Image

Figure Ej (Onapgo 130)

FDA Label Image

Figure Ek (Onapgo 131)

FDA Label Image

Image (Onapgo 32y)

FDA Label Image

Figure Em (Onapgo 132)

FDA Label Image

Image (Onapgo 32z)

FDA Label Image

Image (Onapgo 06s)

FDA Label Image

Image (Onapgo 32aa)

FDA Label Image

Image (Onapgo 125a)

FDA Label Image

Image (Onapgo 32ab)

FDA Label Image

Image (Onapgo 06t)

FDA Label Image

Figure Ey (Onapgo 133)

FDA Label Image

Image (Onapgo 06u)

FDA Label Image

Image (Onapgo 06v)

FDA Label Image

Image (Onapgo 06w)

FDA Label Image

Image (Onapgo 06x)

FDA Label Image

Image (Onapgo 06y)

FDA Label Image

Image (Onapgo 06z)

FDA Label Image

Image (Onapgo 06aa)

FDA Label Image

Image (Onapgo 06ab)

FDA Label Image

Image (Onapgo 06ac)

FDA Label Image

Figure Fc (Onapgo 134)

FDA Label Image

Figure Fd (Onapgo 135)

FDA Label Image

Image (Onapgo 06ad)

FDA Label Image

Image (Onapgo 06ae)

FDA Label Image

Figure Fe (Onapgo 136)

FDA Label Image

Image (Onapgo 06af)

FDA Label Image

Figure Ff (Onapgo 137)

FDA Label Image

Figure Fg (Onapgo 138)

FDA Label Image

Figure Fh (Onapgo 139)

FDA Label Image

Figure Fi (Onapgo 140)

FDA Label Image

Figure Fj (Onapgo 141)

FDA Label Image

Figure Fk (Onapgo 142)

FDA Label Image

Figure Fl (Onapgo 143)

FDA Label Image

Figure Fm (Onapgo 144)

FDA Label Image

Figure Fn (Onapgo 144b)

FDA Label Image

Image (Onapgo 06ak)

FDA Label Image

Image (Onapgo 06al)

FDA Label Image

Image (Onapgo 06am)

FDA Label Image

Image (Onapgo 06an)

FDA Label Image

Image (Onapgo 06ao)

FDA Label Image

Image (Onapgo 06ap)

FDA Label Image

Figure Fp (Onapgo 145)

FDA Label Image

Figure Fq (Onapgo 145a)

FDA Label Image

Figure Fr (Onapgo 146)

FDA Label Image

Figure Fs (Onapgo 147)

FDA Label Image

Figure Ft (Onapgo 148)

FDA Label Image

Figure Fu (Onapgo 149)

FDA Label Image

Image (Onapgo 06aq)

FDA Label Image

Figure Fv (Onapgo 150)

FDA Label Image

Figure Fw (Onapgo 151)

FDA Label Image

Figure Fx (Onapgo 152)

FDA Label Image

Figure Fy (Onapgo 153)

FDA Label Image

Figure Fz (Onapgo 154)

FDA Label Image

Figure Ga (Onapgo 155)

FDA Label Image

Figure Gb (Onapgo 156)

FDA Label Image

Figure Gc (Onapgo 157)

FDA Label Image

Image (Onapgo 06ar)

FDA Label Image

Figure Ge (Onapgo 158)

FDA Label Image

Figure Gf (Onapgo 159)

FDA Label Image

Figure Gg (Onapgo 160)

FDA Label Image

Image (Onapgo 32ac)

FDA Label Image

Figure Gh (Onapgo 161)

FDA Label Image

Figure Gi (Onapgo 162)

FDA Label Image

Image (Onapgo 32ad)

FDA Label Image

Figure Gj (Onapgo 163)

FDA Label Image

Figure Gk (Onapgo 164)

FDA Label Image

Figure Gl (Onapgo 165)

FDA Label Image

Image (Onapgo 06as)

FDA Label Image

Image (Onapgo 32ae)

FDA Label Image

Figure Gm (Onapgo 166)

FDA Label Image

Figure Gn (Onapgo 167)

FDA Label Image

Figure Go (Onapgo 168)

FDA Label Image

Figure Gp (Onapgo 169)

FDA Label Image

Image (Onapgo 06at)

FDA Label Image

Image (Onapgo 32af)

FDA Label Image

Image (Onapgo 32ag)

FDA Label Image

Image (Onapgo 32ah)

FDA Label Image

Figure Gq (Onapgo 170)

FDA Label Image

Figure Gr (Onapgo 171)

FDA Label Image

Image (Onapgo 32ai)

FDA Label Image

Figure Gs (Onapgo 172)

FDA Label Image

Figure Gt (Onapgo 173)

FDA Label Image

Image (Onapgo 06au)

FDA Label Image

Image (Onapgo 174)

FDA Label Image

Image (Onapgo 175)

FDA Label Image

Image (Onapgo 176)

FDA Label Image

Image (Onapgo 177)

FDA Label Image

Image (Onapgo 178)

FDA Label Image

Image (Onapgo 179)

FDA Label Image

Image (Onapgo 180)

FDA Label Image

Image (Onapgo 181)

FDA Label Image

Image (Onapgo 06av)

FDA Label Image

Image (Onapgo 182)

FDA Label Image

Image (Onapgo 183)

FDA Label Image

Image (Onapgo 184)

FDA Label Image

Figure A (Onapgo 185)

FDA Label Image

Figure B, C, D (Onapgo 186)

FDA Label Image

Image (Onapgo 189)

FDA Label Image

Image (Onapgo 190)

FDA Label Image

Image (Onapgo 191)

FDA Label Image

Image (Onapgo 192)

FDA Label Image

Image (Onapgo 193)

FDA Label Image

Image (Onapgo 194)

FDA Label Image

Image (Onapgo 195)

FDA Label Image

Image (Onapgo 196)

FDA Label Image

Image (Onapgo 197)

FDA Label Image

Image (Onapgo 198)

FDA Label Image

Image (Onapgo 199)

FDA Label Image

Image (Onapgo 200)

FDA Label Image

Image (Onapgo 201)

FDA Label Image

Image (Onapgo 202)

FDA Label Image

Image (Onapgo 203)

FDA Label Image

Image (Onapgo 204)

FDA Label Image

Image (Onapgo 205)

FDA Label Image

Image (Onapgo 206)

FDA Label Image

Figure E (Onapgo 207)

FDA Label Image

Figure F (Onapgo 208)

FDA Label Image

Image (Onapgo 209)

FDA Label Image

Image (Onapgo 210)

FDA Label Image

Image (Onapgo 211)

FDA Label Image

Figure G (Onapgo 212)

FDA Label Image

Figure H (Onapgo 213)

FDA Label Image

Image (Onapgo 214)

FDA Label Image

Figure I (Onapgo 215)

FDA Label Image

Image (Onapgo 216)

FDA Label Image

Image (Onapgo 217)

FDA Label Image

Figure J (Onapgo 218)

FDA Label Image

Figure K (Onapgo 219)

FDA Label Image

Image (Onapgo 220)

FDA Label Image

Image (Onapgo 221)

FDA Label Image

Image (Onapgo 222)

FDA Label Image

Image (Onapgo 223)

FDA Label Image

Figure L (Onapgo 224)

FDA Label Image

Image (Onapgo 225)

FDA Label Image

Figure M (Onapgo 226)

FDA Label Image

Image (Onapgo 227)

FDA Label Image

Image (Onapgo 227a)

FDA Label Image

Figure N (Onapgo 228)

FDA Label Image

Image (Onapgo 229)

FDA Label Image

Figure O (Onapgo 230)

FDA Label Image

Image (Onapgo 231)

FDA Label Image

Figure P (Onapgo 232)

FDA Label Image

Image (Onapgo 233)

FDA Label Image

Figure Q (Onapgo 234)

FDA Label Image

Image (Onapgo 235)

FDA Label Image

Image (Onapgo 236)

FDA Label Image

Figure R (Onapgo 237)

FDA Label Image

Image (Onapgo 238)

FDA Label Image

Figure S (Onapgo 239)

FDA Label Image

Image (Onapgo 240)

FDA Label Image

Figure T (Onapgo 241)

FDA Label Image

Image (Onapgo 242)

FDA Label Image

Image (Onapgo 243)

FDA Label Image

Figure U (Onapgo 244)

FDA Label Image

Image (Onapgo 245)

FDA Label Image

Image (Onapgo 246)

FDA Label Image

Figure V (Onapgo 247)

FDA Label Image

Image (Onapgo 248)

FDA Label Image

Figure W (Onapgo 249)

FDA Label Image

Image (Onapgo 250)

FDA Label Image

Image (Onapgo 251)

FDA Label Image

Figure X (Onapgo 252)

FDA Label Image

Image (Onapgo 253)

FDA Label Image

Image (Onapgo 254)

FDA Label Image

Figure Y (Onapgo 255)

FDA Label Image

Image (Onapgo 256)

FDA Label Image

Figure Z (Onapgo 257)

FDA Label Image

Image (Onapgo 258)

FDA Label Image

Image (Onapgo 259)

FDA Label Image

Figure Aa (Onapgo 260)

FDA Label Image

Image (Onapgo 261)

FDA Label Image

Image (Onapgo 262)

FDA Label Image

Figure Ab (Onapgo 263)

FDA Label Image

Image (Onapgo 264)

FDA Label Image

Figure Ac (Onapgo 265)

FDA Label Image

Image (Onapgo 266)

FDA Label Image

Figure Ad (Onapgo 267)

FDA Label Image

Image (Onapgo 268)

FDA Label Image

Figure Ae (Onapgo 269)

FDA Label Image

Image (Onapgo 270)

FDA Label Image

Image (Onapgo 271)

FDA Label Image

Figure Af (Onapgo 272)

FDA Label Image

Figure Ag (Onapgo 273)

FDA Label Image

Image (Onapgo 274)

FDA Label Image

Image (Onapgo 275)

FDA Label Image

Image (Onapgo 276)

FDA Label Image

Image (Onapgo 277)

FDA Label Image

Image (Onapgo 278)

FDA Label Image

Image (Onapgo 279)

FDA Label Image

Image (Onapgo 280)

FDA Label Image

Principal Display Panel (20 mL Cartridge Carton)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.